Regulation of circadian rhythms and hypothalamic-pituitary-adrenal axis: An overlooked interaction in cancer

The Lancet Oncology

Volumn 11, Issue 9, 2010, Pages 816-817

  Innominato, Pasquale F ^a,b,c   Palesh, Oxana ^d   Dhabhar, Firdaus S ^e   Lévi, Francis ^a,b,c   Spiegel, David ^f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYDROCORTISONE;

ANGIOGENESIS; APOPTOSIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CHRONIC STRESS; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; COLORECTAL CANCER; DEPRESSION; DISEASE EXACERBATION; DNA REPAIR; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNE DEFICIENCY; IMMUNITY; LETTER; METASTASIS POTENTIAL; MOLECULAR INTERACTION; PARASYMPATHETIC TONE; PRIORITY JOURNAL; QUALITY OF LIFE; SALIVA LEVEL; SINUS ARRHYTHMIA; SUPRACHIASMATIC NUCLEUS; SURVIVAL TIME; SYMPTOM; TUMOR CELL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

CIRCADIAN RHYTHM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEOPLASMS; PITUITARY-ADRENAL SYSTEM;

EID: 77956145252     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70171-6     Document Type: Letter

References (10)

1. Ondicova K, Mravec B Role of nervous system in cancer aetiopathogenesis. Lancet Oncol 2010, 11:596-601.
2. Levi F, Okyar A, Dulong S, Innominato PF, Clairambault J Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol 2010, 50:377-421.
3. Sephton S, Spiegel D Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?. Brain Behav Immu 2003, 17:321-328.
4. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000, 92:994-1000.
5. Innominato PF, Focan C, Gorlia T, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 2009, 69:4700-4707.
6. Dhabhar FS Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009, 16:300-317.
7. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007, 8:1065-1066.
8. Rich TA Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J Support Oncol 2007, 5:167-174.
9. Reyes-Gibby CC, Wu X, Spitz M, et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008, 9:777-785.
10. Palesh O, Zeitzer JM, Conrad A, et al. Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J Clin Sleep Med 2008, 4:441-449.